FDA Inspection
New York Blood Center, Inc.New York Blood Center, Inc. – FDA Inspection, Jul 17, 2026
Record Details
This FDA Inspection record concerns New York Blood Center, Inc., with an inspection on July 17, 2026, issued by the New York District Office, covering biologics.
View Company Profile
ID · 87f0a51b-259c-4191-b34f-f452b5c5bebe
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1327194
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.100(b)Written SOPs available for use by personnel
- 21 CFR 606.160(a)(1)Person performing, test results, interpretation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of New York Blood Center, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 30, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 19, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 26, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 24, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 5, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for New York Blood Center, Inc.
- FDA Inspection 1181149 - 2022-09-30
- FDA Inspection 1069250 - 2018-09-19
- FDA Inspection 960944 - 2016-02-26
- FDA Inspection 883474 - 2014-06-24
- FDA Inspection 748519 - 2011-10-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.